To the Editor: In regard to the letters to the editor (July21 issue)1 about the excellent article by Cleeland et al. (March3 issue),2 we were surprised, as neurosurgeons treating chronicpain and pain from cancer, at the lack of attention to the surgicaloptions for treating cancer pain. The surgical armamentariumfor pain control is vast and includes implantable drug-deliverydevices, chemical and radiofrequency rhizotomies, central nervoussystem pathway disconnections and augmentation, open decompressionof symptomatic nerve roots or peripheral nerves, and spinalstabilization.3 Recently, even radiosurgical ablation of nucleiand pathways in the central nervous system has . . . [Full Text of this Article]
References
Related Letters:
Treating Cancer Pain
Karnad A. B., Blansfield H. N., Kilwein J. H., Goodman A. N., Marcus C. S., O'Neill W. M., Chambers E. J., Fallon M. T., Bloomer W. D., Cleeland C. S., Jacox A., Carr D. B., Payne R.
Extract |
Full Text
N Engl J Med 1994;
331:199-201, Jul 21, 1994.
Correspondence
This article has been cited by other articles:
Suzuki, T., Miyauchi, T.
(2001). A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol.
280: R1399-R1406
[Abstract][Full Text]
Previous
